New shot aims to cure hepatitis b in landmark trial
Disease control
Recruiting now
This study tests an experimental drug called AHB-137 in 84 adults with chronic hepatitis B who are already on antiviral pills. The goal is to see if the injection can clear the hepatitis B surface antigen (HBsAg) from the blood, which would mean the virus is under control and pat…
Phase: PHASE2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC